loading

Bone Biologics Corp Azioni (BBLG) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Operating Expenses
2.49%
0.7331
0.7153 0.7481 1.0385 1.5549
Operating Income/Loss
2.49%
-0.7331
-0.7153 -0.7481 -1.0385 -1.5549
Nonoperating Income/Loss
0.15%
0.0485
0.0485 0.00756 0.0214 0.0332
Income/Loss From Continuing Operations Before Tax
4.99%
-0.70
-0.6667 -0.7405 -1.0171 -1.5217
Income/Loss From Continuing Operations After Tax
4.99%
-0.70
-0.6667 -0.7405 -1.0171 -1.5217
Net Income/Loss
4.99%
-0.70
-0.6667 -0.7405 -1.0171 -1.5217
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-0.0154
- - - -
Basic Average Shares
88.35%
0.2091
1.7951 0.5578 3.1832 0.3209
Diluted Average Shares
88.35%
0.2091
1.7951 0.5578 3.1832 0.3209
Basic Earnings Per Share
62.16%
-0.14
-0.37 -1.33 -0.32 0.02
Diluted Earnings Per Share
62.16%
-0.14
-0.37 -1.33 -0.32 0.02
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$45.65
price down icon 0.48%
$28.06
price down icon 1.72%
$52.56
price down icon 1.55%
$91.19
price up icon 1.21%
$139.50
price down icon 0.01%
biotechnology ONC
$284.05
price down icon 0.44%
Capitalizzazione:     |  Volume (24 ore):